Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
Amgen Foundation
Awards and Accolades
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Overview
Human Data
AI & Data Science
Multispecifics & Other Modalities
Clinical Trial Innovation
Pipeline
Amgen Science Podcasts
Scientific Advisory Boards
Biosimilars
Clinical Trials
Overview
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
Environmental, Social & Governance Report 2022
Environment, Social and Governance Strategy
Healthy People
Overview
Access to Healthcare
Health Equity
Healthy Society
Overview
Diversity, Inclusion and Belonging
Human Capital Management
Community Investment and Amgen Foundation
Supplier Diversity
Healthy Planet
Overview
Environmental Sustainability
Supplier Sustainability
A Healthy Amgen
Overview
Corporate Governance
Business Ethics and Compliance
Ethical Research
Patient Safety
Product Quality
Cybersecurity and Data Privacy
Reporting and Metrics
Overview
Summary of Data
CDP
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
Amgen Worldwide
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
About
Overview
Amgen History
Mission and Values
Leadership
Amgen Foundation
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Human Data
AI & Data Science
Multispecifics & Other Modalities
Clinical Trial Innovation
Pipeline
Amgen Science Podcasts
Scientific Advisory Boards
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
Scientific Community Initiatives
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
Environmental, Social & Governance Report 2022
Environment, Social and Governance Strategy
Healthy People
Access to Healthcare
Health Equity
Healthy Society
Amgen Foundation and Community Investment
Diversity, Inclusion and Belonging
Human Capital Management
Supplier Diversity
Healthy Planet
Environmental Sustainability
Supplier Sustainability
A Healthy Amgen
Corporate Governance
Business Ethics and Compliance
Ethical Research
Patient Safety
Product Quality
Cybersecurity and Data Privacy
Reporting and Metrics
Summary of Data
CDP
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
X
Home
>
Stories
>
Leveraging Our Science
LEADERSHIP
10.30.2020
CEO Bob Bradway Praises Manufacturing Teams in Puerto Rico Focused on Patient Supply
LEADERSHIP
10.20.2020
At Milken Global Conference, Amgen CEO Bob Bradway Urges More Attention to Predicting and Preventing Chronic Disease Amid COVID-19 Pandemic
LEADERSHIP
10.05.2020
"The World Recognizes We Need Innovation to Defeat COVID-19": Bradway Speaks at Financial Times Conference
SCIENCE & INNOVATION
09.01.2020
Large deCODE Study Tests Durability of Antibody Response to SARS-CoV-2 Infection
SCIENCE & INNOVATION
07.23.2020
Global Network of Adaptive Clinical Trials Is Helping Fight COVID-19
LEADERSHIP
07.16.2020
CEO Bob Bradway Discusses Industry’s COVID-19 Response at
Fortune
Conference
LEADERSHIP
06.09.2020
Dr. David Reese Discusses Amgen’s COVID-19 Work at ‘WSJ Tech Health’ Event
LEADERSHIP
04.24.2020
“We’re Gaining Ground Fast”
SCIENCE & INNOVATION
04.24.2020
On DNA Day, A Salute to the ‘Magic’ Genes That Give Us a Fighting Chance Against Viruses
SCIENCE & INNOVATION
04.22.2020
Highlights from Amgen and Adaptive Biotechnologies Webinar on Research to Find New Antibody Treatment for COVID-19
SCIENCE & INNOVATION
04.14.2020
deCODE Study in
NEJM
Sheds Light on SARS-CoV-2 Genetics and True Prevalence in Iceland
LEADERSHIP
04.07.2020
Can Therapeutic Antibodies Offer Hope for COVID-19 Patients?
Load more
Loading...
